Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER-2 Negative Breast Cancer
Interventions: DRUG: Utidelone Combined with Bevacizumab
Sponsor: Henan Cancer Hospital
Collaborators: Qilu Pharmaceutical Co., Ltd.|Beijing Biostar Pharmaceuticals Co., Ltd.